An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
19 02 2019
Historique:
received: 31 08 2018
revised: 16 11 2018
accepted: 14 12 2018
pubmed: 3 2 2019
medline: 14 8 2019
entrez: 3 2 2019
Statut: ppublish

Résumé

Anti-HIV broadly neutralizing antibodies (bnAbs) have revealed vaccine targets on the virus's envelope (Env) protein and are themselves promising immunotherapies. The efficacy of bnAb-based therapies and vaccines depends in part on how readily the virus can escape neutralization. Although structural studies can define contacts between bnAbs and Env, only functional studies can define mutations that confer escape. Here, we mapped how all possible single amino acid mutations in Env affect neutralization of HIV by nine bnAbs targeting five epitopes. For most bnAbs, mutations at only a small fraction of structurally defined contact sites mediated escape, and most escape occurred at sites near, but not in direct contact with, the antibody. The Env mutations selected by two pooled bnAbs were similar to those expected from the combination of the bnAbs's independent action. Overall, our mutation-level antigenic atlas provides a comprehensive dataset for understanding viral immune escape and refining therapies and vaccines.

Identifiants

pubmed: 30709739
pii: S1074-7613(18)30565-X
doi: 10.1016/j.immuni.2018.12.017
pmc: PMC6435357
mid: NIHMS1517127
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Epitopes 0
HIV Antibodies 0
env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Pagination

520-532.e3

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI140891
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIDA NIH HHS
ID : DP1 DA039543
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI120961
Pays : United States
Organisme : NIH HHS
ID : S10 OD020069
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI141707
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

J Virol. 1993 Nov;67(11):6897-902
pubmed: 8411395
J Virol. 2012 Apr;86(8):4394-403
pubmed: 22345481
Nat Med. 2005 Jun;11(6):615-22
pubmed: 15880120
Nature. 2012 Nov 15;491(7424):406-12
pubmed: 23151583
Cell. 2014 Sep 25;159(1):69-79
pubmed: 25259921
J Virol. 2016 Sep 29;90(20):9471-82
pubmed: 27512064
Elife. 2018 Mar 28;7:
pubmed: 29590010
J Virol. 2015 Oct 28;90(2):829-41
pubmed: 26512079
Science. 2016 May 13;352(6287):828-33
pubmed: 27174988
PLoS Med. 2008 Jan 3;5(1):e9
pubmed: 18177204
Cell Host Microbe. 2017 Jun 14;21(6):777-787.e4
pubmed: 28579254
Science. 2014 Nov 7;346(6210):759-63
pubmed: 25298114
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11530-5
pubmed: 21690407
PLoS Comput Biol. 2013;9(5):e1003046
pubmed: 23696718
Nucleic Acids Res. 2015 Jul 1;43(W1):W213-9
pubmed: 26044712
PLoS Pathog. 2018 Jul 5;14(7):e1007159
pubmed: 29975771
Virology. 2017 May;505:193-209
pubmed: 28279830
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E564-E573
pubmed: 29311326
PLoS Pathog. 2009 Apr;5(4):e1000365
pubmed: 19343217
PLoS Pathog. 2016 Dec 13;12(12):e1006114
pubmed: 27959955
J Clin Microbiol. 2006 Dec;44(12):4357-62
pubmed: 17050820
Nature. 2015 Jun 25;522(7557):487-91
pubmed: 25855300
BMC Bioinformatics. 2015 May 20;16:168
pubmed: 25990960
J Virol. 2011 Sep;85(17):8954-67
pubmed: 21715490
Nature. 2016 Jul 28;535(7613):556-60
pubmed: 27338952
Science. 2016 May 20;352(6288):997-1001
pubmed: 27199429
Immunity. 1999 Apr;10(4):431-8
pubmed: 10229186
Bioinformatics. 2017 Nov 15;33(22):3645-3647
pubmed: 29036507
Sci Transl Med. 2014 May 14;6(236):236ra63
pubmed: 24828077
Immunity. 2014 May 15;40(5):657-68
pubmed: 24768347
Nat Struct Mol Biol. 2016 Oct;23(10):906-915
pubmed: 27617431
J Virol. 2015 Jan 15;89(2):894-907
pubmed: 25378497
Immunol Rev. 2017 Jan;275(1):313-323
pubmed: 28133794
Science. 2013 Dec 20;342(6165):1484-90
pubmed: 24179160
Nat Commun. 2018 Apr 11;9(1):1386
pubmed: 29643370
Immunol Rev. 2017 Jan;275(1):296-312
pubmed: 28133803
Nat Struct Mol Biol. 2017 Apr;24(4):370-378
pubmed: 28218750
Cell. 2016 May 5;165(4):813-26
pubmed: 27114034
Science. 2009 Oct 9;326(5950):285-9
pubmed: 19729618
Nature. 2011 Nov 23;480(7377):336-43
pubmed: 22113616
J Virol. 2016 Sep 29;90(20):9224-36
pubmed: 27489265
Science. 2016 Mar 4;351(6277):1043-8
pubmed: 26941313
N Engl J Med. 2016 Nov 24;375(21):2037-2050
pubmed: 27959728
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
PLoS Pathog. 2013 Sep;9(9):e1003618
pubmed: 24068931
Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Dec;88(6):062705
pubmed: 24483484
Immunity. 2016 Jul 19;45(1):31-45
pubmed: 27438765
EBioMedicine. 2016 Oct;12:196-207
pubmed: 27612593
Sci Transl Med. 2015 Dec 23;7(319):319ra206
pubmed: 26702094
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Genetics. 2010 May;185(1):293-303
pubmed: 20157005
PLoS Pathog. 2016 Mar 30;12(3):e1005520
pubmed: 27028935
Cell Host Microbe. 2017 Aug 9;22(2):247-248
pubmed: 28799910
Nature. 2013 Nov 14;503(7475):277-80
pubmed: 24172896
Immunity. 2018 May 15;48(5):855-871
pubmed: 29768174
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3268-77
pubmed: 23115339
J Virol. 2015 Apr;89(8):4201-13
pubmed: 25631091
J Virol. 2012 Nov;86(22):12105-14
pubmed: 22933284
J Virol. 2006 Jan;80(2):835-44
pubmed: 16378985
PLoS Pathog. 2018 Aug 20;14(8):e1007238
pubmed: 30125330
Nature. 2018 Sep;561(7724):479-484
pubmed: 30258136
Nat Med. 2018 Nov;24(11):1701-1707
pubmed: 30258217
PLoS Pathog. 2013 Oct;9(10):e1003738
pubmed: 24204277
J Mol Biol. 1993 Dec 5;234(3):554-63
pubmed: 7504735
Immunity. 2017 Apr 18;46(4):690-702
pubmed: 28423342
Virus Evol. 2017 Mar 02;3(1):vex003
pubmed: 28458914
Nature. 2011 Sep 22;477(7365):466-70
pubmed: 21849977
Immunol Rev. 2017 Jan;275(1):21-32
pubmed: 28133813
Nat Med. 2017 Feb;23(2):185-191
pubmed: 28092665
Elife. 2017 May 26;6:
pubmed: 28548638
Nat Commun. 2016 May 23;7:11660
pubmed: 27212475
Biochemistry. 1993 Jul 13;32(27):6828-35
pubmed: 7687461
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
PLoS Pathog. 2014 Jul 24;10(7):e1004271
pubmed: 25058619
PLoS Pathog. 2018 Mar 5;14(3):e1006860
pubmed: 29505593
Nature. 2012 Dec 6;492(7427):118-22
pubmed: 23103874

Auteurs

Adam S Dingens (AS)

Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Molecular & Cellular Biology PhD Program, University of Washington, Seattle, WA 98195, USA; Division of Human Biology and Epidemiology Program, Seattle, WA 98109, USA.

Dana Arenz (D)

Division of Human Biology and Epidemiology Program, Seattle, WA 98109, USA.

Haidyn Weight (H)

Division of Human Biology and Epidemiology Program, Seattle, WA 98109, USA.

Julie Overbaugh (J)

Division of Human Biology and Epidemiology Program, Seattle, WA 98109, USA. Electronic address: joverbau@fredhutch.org.

Jesse D Bloom (JD)

Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Howard Hughes Medical Institute, Seattle, WA 98109, USA. Electronic address: jbloom@fredhutch.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH